Potential of metabolic agents as adjunct therapies in heart failure

Abozguia, Khalid, Nallur Shivu, Ganesh, Phan, Thanh Trung, Ahmed, Ibrar, Maher, Abdul R and Frenneaux, Michael (2007) Potential of metabolic agents as adjunct therapies in heart failure. Future Cardiology, 3 (5). pp. 525-35. ISSN 1479-6678

Full text not available from this repository.


Heart failure continues to have a significant morbidity and mortality rate despite several recent advances in treatment such as additional neurohumoral blockades and cardiac resynchronization therapy. There is emerging evidence that, irrespective of etiology, heart failure is associated with an energetic disorder and that this may contribute to the pathogenesis of the syndrome. Recently, a number of studies have suggested that some metabolic agents may have potential as adjunctive therapy in patients with heart failure. These agents cause a shift of myocardial-substrate utilization away from free fatty acids toward glucose. Free fatty acid utilization consumes more oxygen to generate an equivalent amount of energy compared with glucose. Some of these agents are also effective antianginals, presumably by reducing the myocardial oxygen requirement. In this review we will discuss some of the current issues and progresses relating to metabolic manipulation in heart failure.

Item Type: Article
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups: Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health
Depositing User: Pure Connector
Date Deposited: 28 Aug 2015 15:44
Last Modified: 23 Apr 2023 01:13
URI: https://ueaeprints.uea.ac.uk/id/eprint/54189
DOI: 10.2217/14796678.3.5.525

Actions (login required)

View Item View Item